株式会社極東書店トップ > 商品一覧 > Essential CNS Drug Development.
商品詳細
Essential CNS Drug Development.
・ISBN 978-0-521-76606-7 hard GB£ 82.00
¥25,977.- (税込) ※(※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
お気に入り
★★★
| 著者・編者 | Kalali, Amir / Preskorn, Sheldon / Kwentus, Joseph / Stahl, Stephen M. (eds.), |
|---|---|
| 出版社 | (Cambridge University Press, UK) |
| 出版年月 | 2012 |
| ページ数 | 215 pp. |
| 言語 | ENG |
| ニュース番号 | <A00-3623> |
解説
Central Nervous System disorders have an enormous impact on individuals and on society as a whole. The development of better treatments is crucial and is a major focus of pharmaceutical and biotechnology companies. This book explains the complicated process of CNS drug development in a way that is engaging for any interested professional or student. Chapters cover each stage of drug development, from pre-clinical research through all phases of clinical trials, to reporting to the regulatory authorities. Other key issues covered include strategic considerations, regulatory constraints, dissemination of results and ethical considerations. The user-friendly format and style enable readers to find important information quickly and easily. Written and edited by experts from different sectors actively engaged in CNS drug development, this is a unique resource for drug developers, investigators, academics and clinicians.